Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma

Completed · Not applicable

Conditions studied: Sarcoma

In brief

This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard" may help patients understand the disease better and help the patient's medical team manage their care more efficiently. The oncology dashboard tool may help patients understand the disease better and may help improve the efficiency of their medical care.

Key facts

Study ID

NCT05216029

Run by

M.D. Anderson Cancer Center

People needed

92

Starts

2015-10-01

Expected to finish

2026-03-18

Last updated by the study team

2026-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with sarcoma on active chemotherapy/targeted therapy
• Patients must have stable to mildly progressive disease or better on baseline assessment
• Baseline measurement and follow-up measurement have to be performed on the same treatment for consistency. If patients with progressive disease are included into the study at baseline, follow-up measurement will be on a different treatment. Invariable, initiation of a new treatment, in the setting of progressive disease, lengthens oncology workflow which would affect the post measurement
• Patients must have been on the same treatment for at least 6 weeks
• Patients must have at least 3 prior imaging studies of the same body part/tracked lesion/area of interest separated by 6 weeks or more between studies
• Patients should be continuing same therapy for the next 6-8 weeks
• Patients must have plan for follow-up with imaging studies at MD Anderson Cancer Center (MDACC) while on therapy
• Patients who are receiving therapy outside of MDACC but having their follow-up imaging at MDACC are eligible
• >= 18 years of age

You may not qualify if…

• Expected survival of less than 8 weeks
• Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 4
• Non- English-speaking patients and patients with cognitive impairment who cannot complete the questionnaire

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.